Reports N Reports

U.S. General Anesthesia Drugs Market Overview and Forecast to 2020

Press Release   •   Aug 03, 2015 08:54 EDT

Rapid Rise in Aging Population, Rising Prevalence of Cardiovascular and Respiratory System-related Diseases, and Rising Number of Emergency Surgeries to Drive the Growth of the U.S. General Anesthesia DrugsMarket .

The report segments the U.S. general anesthesia drugs market on the basis of molecule and route of administration. On the basis of molecules, the market is divided into Propofol, Benzodiazepine, Ketamine (S-(+)-Ketamine HCL), and Methohexital Sodium.Propofol is expected to be fastest-growing segment, owing to its greater preference and rapid onset of action.

Browse 42 market data tables & 28 figures spread through 114 pages and in-depth TOC on "U.S. General Anesthesia Drugs Market by Molecule (Propofol, Benzodiazepines, ketamine(s(+) ketamine HCl), Methohexital Sodium), route of administration (Intravenous, Inhalational), Supply Chain (GPOs, Distributors), Competitive - Analysis Forecast to 2020" at - http://www.rnrmarketresearch.com/u-s-general-anesthesia-drugs-market-2011-2015-market-entry-strategy-propofol-midazolam-diazepam-fospropofol-disodium-sodium-pentothal-ketamine-methohexital-sodium-pentobarbital-etomida-market-report.html .

On the basis of route of administration, the U.S. general anesthesia drugs market is bifurcated into intravenous and inhalational. The intravenous segment is expected to account for the largest share of the U.S. general anesthesia drugs market in 2015. Greater patient compliance and less number of side effects as compared to inhalational anesthetics are driving the growth of this market.

Acquisitions was the most preferred strategy adopted by major industry players in order to increase their market shares and cater to unmet needs.

This report provides insights on the qualitative data, market size, growth of various segments and sub segments, and prominent players in this market. The qualitative data covers various levels of industry analysis such as market dynamics (drivers, restraints, opportunities, and threats). The report also offers market sizes and data on the growth of various segments in the industry. It focuses on emerging and high-growth segments, high-growth regions, and government initiatives.

The report also provides a company profiles section, which comprises basic views on the key players in the U.S. general anesthesia drugs market and their product portfolios, developments, and strategies adopted to maintain and increase their market shares. The above-mentioned market research data, current market size, and forecast of future trends will help key players and new entrants to make the necessary decisions regarding product offerings, geographical focus, change in approach, R&D investments for innovations in products and technologies, and levels of output in order to remain successful.

Reasons to Buy the Report:

This report will enable both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help these firms, garner a greater market share. Firms purchasing the report can use any one or a combination of the below-mentioned three strategies (market penetration, competitive assessment, and market entry).

The report provides insights on the following pointers:

  • §Market Penetration: Comprehensive information on product portfolios of the top players in the U.S. general anesthesia drugs market. The report analyzes the U.S. general anesthesia drugsmarket by molecule and mode of administration.
  • §Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments, and product portfolios of the leading players in the U.S. general anesthesia drugs market
  • §Market Entry: Comprehensive information about business strategies for entering the U.S. general anesthesia drugs market

Order the report (Priced USD 4650 Single User License) at – http://www.rnrmarketresearch.com/contacts/purchase?rname=80152 .

Table of Contents

1 Introduction
2 Research Methodology
3 Market Overview
4 Distribution Structure
4.1 U.S. Ketamine Market: Distribution Structure
4.2 U.S. Ketamine Market, 2010–2014
4.3 Major Legal Trends for Controlled Substances
4.4 Product Category Enumeration
4.5 Market Share, 2010–2014
5 Product Analysis
5.1 Anesthesia Drugs Market Segmentation in the U.S.
5.2 U.S.: Market Share, General Anesthetics, 2010–2014
5.3 Competition in the U.S.
5.4 Local Sales Price
5.5 Potential Buyers in the U.S.
6 U.S. General Anaesthesia Drugs Market: Key Information
6.1 Import & Export Systems in U.S.
6.2 Top Related Exhibitions
6.3 Description of Potential Buyers

7 Strategic Recommendations for Entering the U.S. General Anesthesia Drugs Market

8 Company Profiles
8.1 Introduction
8.2 Abbott Laboratories
8.3 Astrazeneca PLC
8.4 Baxter International Inc.
8.5 Hikma Pharmaceuticals PLC
8.6 Mylan N.V.
8.7 Eisai Co., Ltd.
8.8 Fresenius Se & Co. Kgaa
8.9 Hospira, Inc.
8.10 Par Pharmaceutical Companies, Inc.
9 Appendix

Priced at USD 4650 for a single user PDF, a discount on “U.S. General Anesthesia Drugs Market by Molecule (Propofol, Benzodiazepines, ketamine(s(+) ketamine HCl), Methohexital Sodium), route of administration (Intravenous, Inhalational), Supply Chain (GPOs, Distributors), Competitive - Analysis Forecast to 2020” can be requested at - http://www.rnrmarketresearch.com/contacts/discount?rname=80152 .

Related Market Reports:

“The Pharmaceutical Excipients Market by Products (Organic chemicals, Inorganic Chemicals), Functionality (Fillers, Binders, Lubricants, Preservatives), & by Route of Administration (Oral, Topical, Parenteral, Others) – Global Forecast to 2019” research report is now available with RnRMarketResearch.com. The report has profiled the leading players of this market along with the strategies available at - http://www.rnrmarketresearch.com/pharmaceutical-excipients-market-by-products-carbohydrates-oleochemicals-petrochemicals-polymers-microcrystalline-cellulose-sugar-calcium-carbonate-by-functionality-fillers-binders-lubric-market-report.html .

"Weight Loss and Weight Management Market by Equipment (Fitness Equipment (Treadmill, Stair Steppers)), Surgical Equipment (Adjustable Gastric Band, Gastric Bypass), Diet (Weight Loss Meals, Diet Soft Drinks), Weight Loss Services – Forecast to 2019” research report is now available with RnRMarketResearch.com The report has profiled the leading players of this market along with the strategies available at - http://www.rnrmarketresearch.com/weight-loss-and-weight-management-market-by-equipment-fitness-equipment-treadmill-stair-steppers-surgical-equipment-adjustable-gastric-band-gastric-bypass-diet-weight-loss-meals-diet-soft-market-report.html .

Explore more reports on ‘Life Sciences’ at – http://www.rnrmarketresearch.com/reports/life-sciences .


About Us:

RnRMarketResearch.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 100+ leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.